<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fuad El-Hibri Organization Blog &#187; Vice President</title>
	<atom:link href="http://fuad-elhibri.org/tag/vice-president/feed/" rel="self" type="application/rss+xml" />
	<link>http://fuad-elhibri.org</link>
	<description>Fuad El-Hibri Online</description>
	<lastBuildDate>Mon, 30 Aug 2010 06:38:49 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript</title>
		<link>http://fuad-elhibri.org/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/</link>
		<comments>http://fuad-elhibri.org/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/#comments</comments>
		<pubDate>Thu, 13 Aug 2009 17:29:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Anthrax]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Chief executive officer]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Infectious disease]]></category>
		<category><![CDATA[Investor relations]]></category>
		<category><![CDATA[Profile]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[fuad]]></category>
		<category><![CDATA[fuad el-hibri]]></category>
		<category><![CDATA[Chief financial officer]]></category>
		<category><![CDATA[Chief operating officer]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.org/?p=100</guid>
		<description><![CDATA[Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
 
Executives
Robert G. Burrows &#8211; Vice President, Investor Relations
Fuad El-Hibri &#8211; Chairman of the Board, Chief Executive Officer
R. Don Elsey &#8211; Chief Financial Officer
Daniel J. Abdun-Nabi &#8211; President, Chief Operating Officer
W. James Jackson, Ph.D. &#8211; Senior Vice President and Chief Scientific Officer
 
Analysts
Eric Schmidt [...]


Related posts:<ol><li><a href='http://fuad-elhibri.org/2010/08/03/emergent-revises-upward-2010-financial-forecast/' rel='bookmark' title='Permanent Link: Emergent Revises Upward 2010 Financial Forecast'>Emergent Revises Upward 2010 Financial Forecast</a> <small>Company anticipates total revenues of $275 to $300 million and...</small></li><li><a href='http://fuad-elhibri.org/2009/12/16/bad-news-clouds-two-bio-defense-stocks/' rel='bookmark' title='Permanent Link: Bad News Clouds Two Bio Defense Stocks'>Bad News Clouds Two Bio Defense Stocks</a> <small>Written by Staff and Wire Reports Tuesday, 08 December 2009...</small></li><li><a href='http://fuad-elhibri.org/2010/06/07/emergent-biosolutions-to-participate-in-june-2010-investor-conferences/' rel='bookmark' title='Permanent Link: Emergent BioSolutions to Participate in June 2010 Investor Conferences'>Emergent BioSolutions to Participate in June 2010 Investor Conferences</a> <small>Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the...</small></li></ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[<p>Emergent BioSolutions Inc., (<a title="More opinion and analysis of EBS" href="http://seekingalpha.com/symbol/ebs">EBS</a>)</p>
<p>Q2 2009 Earnings Call</p>
<p>August 6, 2009 5:00 pm ET</p>
<p><strong> </strong></p>
<p><strong>Executives</strong></p>
<p>Robert G. Burrows &#8211; Vice President, <span class="zem_slink">Investor Relations</span></p>
<p><a href="http://seekingalpha.com/article/154549-emergent-biosolutions-inc-q2-2009-earnings-call-transcript">Fuad El-Hibri</a> &#8211; <span class="zem_slink">Chairman of the Board</span>, <span class="zem_slink">Chief Executive Officer</span></p>
<p>R. Don Elsey &#8211; <span class="zem_slink">Chief Financial Officer</span></p>
<p>Daniel J. Abdun-Nabi &#8211; President, <span class="zem_slink">Chief Operating Officer</span></p>
<p>W. James Jackson, Ph.D. &#8211; <span class="zem_slink">Senior Vice President</span> and <span class="zem_slink">Chief Scientific Officer</span></p>
<p><strong> </strong></p>
<p><strong>Analysts</strong></p>
<p>Eric Schmidt &#8211; Cowen &amp; Company</p>
<p>David Moskowitz &#8211; Caris &amp; Company</p>
<p>Mona Ashiya &#8211; J.P. Morgan</p>
<p>Sean Long – Kennedy Capital Management</p>
<p><strong> </strong></p>
<p><strong>Presentation</strong></p>
<p><strong> </strong></p>
<p><strong>Operator</strong></p>
<p>Welcome to the Emergent BioSolutions Incorporated second quarter 2009 financial results conference call. (Operator Instructions) I would now like to turn the call over to Mr. Robert Burrows.</p>
<p><strong>Robert Burrows</strong></p>
<p>Good afternoon ladies and gentlemen. My name is Robert Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss Emergent BioSolutions financial results for the second quarter and first six months of 2009. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions&#8230;.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/0d5c2847-b3f5-4c15-9506-c8f09e1b19b9/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=0d5c2847-b3f5-4c15-9506-c8f09e1b19b9" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>


<p>Related posts:<ol><li><a href='http://fuad-elhibri.org/2010/08/03/emergent-revises-upward-2010-financial-forecast/' rel='bookmark' title='Permanent Link: Emergent Revises Upward 2010 Financial Forecast'>Emergent Revises Upward 2010 Financial Forecast</a> <small>Company anticipates total revenues of $275 to $300 million and...</small></li><li><a href='http://fuad-elhibri.org/2009/12/16/bad-news-clouds-two-bio-defense-stocks/' rel='bookmark' title='Permanent Link: Bad News Clouds Two Bio Defense Stocks'>Bad News Clouds Two Bio Defense Stocks</a> <small>Written by Staff and Wire Reports Tuesday, 08 December 2009...</small></li><li><a href='http://fuad-elhibri.org/2010/06/07/emergent-biosolutions-to-participate-in-june-2010-investor-conferences/' rel='bookmark' title='Permanent Link: Emergent BioSolutions to Participate in June 2010 Investor Conferences'>Emergent BioSolutions to Participate in June 2010 Investor Conferences</a> <small>Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the...</small></li></ol></p>
<p>Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.org/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Emergent BioSolutions hands out bonuses</title>
		<link>http://fuad-elhibri.org/2009/08/05/emergent-biosolutions-hands-out-bonuses/</link>
		<comments>http://fuad-elhibri.org/2009/08/05/emergent-biosolutions-hands-out-bonuses/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 16:25:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Chief executive officer]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Profile]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[fuad]]></category>
		<category><![CDATA[fuad el-hibri]]></category>
		<category><![CDATA[social network]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Executive]]></category>
		<category><![CDATA[Rockville]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.org/?p=87</guid>
		<description><![CDATA[Washington Business Journal reports
Emergent BioSolutions hands out bonuses
Bonus may be a bad word right now — but not for a biotech that is actually making money.
Alongside minimal pay raises, Emergent BioSolutions Inc. execs received bonuses in 2008 that increased anywhere from 5 percent to 43 percent from their 2007 bonuses. Fuad El-Hibri, chief executive officer [...]


Related posts:<ol><li><a href='http://fuad-elhibri.org/2010/05/18/emergent-biosolutions-recognized-as-biotechnology-firm-of-the-year-by-tech-council-of-maryland/' rel='bookmark' title='Permanent Link: Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland'>Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland</a> <small>ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS)...</small></li><li><a href='http://fuad-elhibri.org/2010/03/15/emergent-biosolutions-chairman-and-ceo-fuad-el-hibri-recognized-as-outstanding-international-business-leader/' rel='bookmark' title='Permanent Link: Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader'>Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader</a> <small>ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions...</small></li><li><a href='http://fuad-elhibri.org/2009/12/17/fuad-el-hibri-king-of-anthrax-wins-an-award-from-ernst-young/' rel='bookmark' title='Permanent Link: Fuad el-Hibri, king of anthrax, wins an award from Ernst &#038; Young'>Fuad el-Hibri, king of anthrax, wins an award from Ernst &#038; Young</a> <small> Marie-José Daoud Awarded the Ernst and Young prize for...</small></li></ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[<h3><a href="http://washington.bizjournals.com/washington/stories/2009/03/16/daily73.html">Washington Business Journal </a>reports</h3>
<h3><span class="zem_slink">Emergent BioSolutions</span> hands out bonuses</h3>
<p>Bonus may be a bad word right now — but not for a biotech that is actually making money.</p>
<p>Alongside minimal pay raises, Emergent BioSolutions Inc. execs received bonuses in 2008 that increased anywhere from 5 percent to 43 percent from their 2007 bonuses. <a href="http://en.wikipedia.org/wiki/Fuad_El-Hibri">Fuad El-Hibri</a>, <span class="zem_slink">chief executive officer</span> and chairman of the <span class="zem_slink">Rockville</span> <span class="zem_slink">company</span>, got the lowest increase, but the highest bonus at $323,250. The highest increase was doled out to Kyle Keese, <span class="zem_slink">senior vice president</span> of <span class="zem_slink">manufacturing operations</span>, who took home a $96,460 bonus for 2008.</p>
<p>Though, at least one <span class="zem_slink">manager</span>’s perk wasn’t quite so perky last year. Robert Kramer, who stepped down in January as head of Emergent’s manufacturing subsidiary and instead will manage a contract that the company hopes to nail with the federal <span class="zem_slink">government</span> this year, got a 48 percent decrease in his bonus from 2007, bringing his 2008 figure to $78,815&#8230;.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/2071be82-dbb8-4280-9297-2a11fa6279d4/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=2071be82-dbb8-4280-9297-2a11fa6279d4" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>


<p>Related posts:<ol><li><a href='http://fuad-elhibri.org/2010/05/18/emergent-biosolutions-recognized-as-biotechnology-firm-of-the-year-by-tech-council-of-maryland/' rel='bookmark' title='Permanent Link: Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland'>Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland</a> <small>ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS)...</small></li><li><a href='http://fuad-elhibri.org/2010/03/15/emergent-biosolutions-chairman-and-ceo-fuad-el-hibri-recognized-as-outstanding-international-business-leader/' rel='bookmark' title='Permanent Link: Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader'>Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader</a> <small>ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions...</small></li><li><a href='http://fuad-elhibri.org/2009/12/17/fuad-el-hibri-king-of-anthrax-wins-an-award-from-ernst-young/' rel='bookmark' title='Permanent Link: Fuad el-Hibri, king of anthrax, wins an award from Ernst &#038; Young'>Fuad el-Hibri, king of anthrax, wins an award from Ernst &#038; Young</a> <small> Marie-José Daoud Awarded the Ernst and Young prize for...</small></li></ol></p>
<p>Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.</p>]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.org/2009/08/05/emergent-biosolutions-hands-out-bonuses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
